You are currently viewing Poehling Capital Management INC . Buys 547 Shares of Kenvue Inc . ( NYSE : KVUE ) 


##
Representation image: This image is an artistic interpretation related to the article theme.

Poehling Capital Management INC . Buys 547 Shares of Kenvue Inc . ( NYSE : KVUE ) ##

This move signifies a continued interest in Kenvue, a company focused on developing and marketing innovative, high-quality, and affordable healthcare products. **Key Takeaways:**

* **Increased Stake:** Poehling Capital Management INC. has increased its stake in Kenvue Inc.

This move suggests that analysts believe the company is currently undervalued and has potential for growth. **Detailed Analysis of the Summary**

The summary highlights a significant development in the market perception of Ken Vue. The analyst ratings and price target changes provide valuable insights into the current sentiment surrounding the company.

**Financial Performance**
Kenvue Inc. reported a net income of $1.1 billion in the fiscal year 2022, representing a significant increase from the previous year. This growth was driven by strong revenue growth, particularly in the company’s core business segments. **Market Position**
Kenvue Inc.

Kenvue Increases Dividend The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 28th. Investors of record on Wednesday, August 14th were given a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a yield of 3.51%. The ex-dividend date of this dividend was Wednesday, August 14th. This is a boost from Kenvue’s previous quarterly dividend of $0.20. Kenvue’s dividend payout ratio is 105.13%. Kenvue Profile (Free Report) Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

This summary provides information about the holdings of a hedge fund, focusing on the specific case of KVUE. The summary highlights the importance of understanding the holdings of hedge funds, as they can provide valuable insights into market trends and investment strategies. It also emphasizes the need for investors to be aware of the potential risks associated with investing in hedge funds.

Leave a Reply